Tibet AIM Pharm. Inc. (SHE:002826)
China
· Delayed Price · Currency is CNY 21.32
-0.18 (-0.84%)
Mar 11, 2026, 10:25 AM CST
Tibet AIM Pharm. Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 85.87 | 45.93 | 15.39 | 44.14 | 42.48 | 41.09 | Upgrade
|
| Depreciation & Amortization | 21.55 | 21.55 | 24.14 | 22.7 | 23.74 | 16.74 | Upgrade
|
| Other Amortization | 0.14 | 0.14 | 1.78 | 1.78 | 1.78 | - | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.04 | 0.04 | -0.03 | - | -0.03 | 0.12 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.2 | 0.2 | 19.93 | 0.08 | 0.08 | 1.78 | Upgrade
|
| Loss (Gain) From Sale of Investments | -3.51 | -3.51 | -2.31 | -1.48 | -0.91 | -0.55 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.67 | 0.67 | -7.02 | 6.64 | -1.13 | - | Upgrade
|
| Other Operating Activities | -1.69 | 2.5 | 0.39 | -0.36 | -1.03 | 1.62 | Upgrade
|
| Change in Accounts Receivable | -14.57 | -14.57 | 170.44 | 6.1 | 86.19 | -44.79 | Upgrade
|
| Change in Inventory | 17.63 | 17.63 | -13.42 | -12.09 | -12.52 | 8.78 | Upgrade
|
| Change in Accounts Payable | -8.53 | -8.53 | -46.74 | 47.54 | -52.44 | 77.63 | Upgrade
|
| Change in Other Net Operating Assets | 48.01 | 48.01 | 3.04 | -43.92 | 19.75 | 2.95 | Upgrade
|
| Operating Cash Flow | 147.33 | 111.57 | 166.88 | 68.45 | 109.52 | 101.74 | Upgrade
|
| Operating Cash Flow Growth | -27.28% | -33.14% | 143.79% | -37.50% | 7.65% | 71.84% | Upgrade
|
| Capital Expenditures | -8.32 | -12.24 | -3.18 | -3.2 | -25.2 | -38.43 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.17 | 0.14 | 0.08 | 0 | 0.06 | 0.04 | Upgrade
|
| Cash Acquisitions | - | - | - | - | -29.45 | - | Upgrade
|
| Investment in Securities | -91.46 | 28.54 | -42.14 | - | - | 30 | Upgrade
|
| Other Investing Activities | 2.95 | 2.56 | 2.24 | 1.48 | 0.91 | 0.55 | Upgrade
|
| Investing Cash Flow | -96.66 | 19 | -43 | -1.72 | -53.68 | -7.85 | Upgrade
|
| Short-Term Debt Issued | - | 22.8 | 11 | 50 | - | 110 | Upgrade
|
| Total Debt Issued | 37.63 | 22.8 | 11 | 50 | - | 110 | Upgrade
|
| Short-Term Debt Repaid | - | -11 | -50 | - | -40 | -140 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | - | -0.09 | - | Upgrade
|
| Total Debt Repaid | -19.14 | -11 | -50 | - | -40.09 | -140 | Upgrade
|
| Net Debt Issued (Repaid) | 18.49 | 11.8 | -39 | 50 | -40.09 | -30 | Upgrade
|
| Repurchase of Common Stock | -50.03 | -50.03 | -0.02 | -2.64 | -3.01 | -7.49 | Upgrade
|
| Common Dividends Paid | -23.81 | -6.04 | -20.28 | -19.77 | -15.27 | -7.67 | Upgrade
|
| Other Financing Activities | 74.54 | - | - | - | -0.83 | -1.62 | Upgrade
|
| Financing Cash Flow | 19.18 | -44.26 | -59.3 | 27.59 | -59.2 | -46.78 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.06 | 0.24 | -0 | -0.02 | -0.02 | -0.08 | Upgrade
|
| Net Cash Flow | 69.79 | 86.54 | 64.57 | 94.31 | -3.38 | 47.03 | Upgrade
|
| Free Cash Flow | 139.01 | 99.33 | 163.7 | 65.26 | 84.33 | 63.31 | Upgrade
|
| Free Cash Flow Growth | -27.27% | -39.32% | 150.86% | -22.62% | 33.20% | - | Upgrade
|
| Free Cash Flow Margin | 22.13% | 15.24% | 24.54% | 7.62% | 11.62% | 10.51% | Upgrade
|
| Free Cash Flow Per Share | 0.77 | 0.54 | 0.85 | 0.34 | 0.44 | 0.34 | Upgrade
|
| Cash Interest Paid | - | - | - | - | 0.83 | 1.62 | Upgrade
|
| Cash Income Tax Paid | 100.22 | 96.36 | 95.33 | 86.77 | 86.95 | 54.79 | Upgrade
|
| Levered Free Cash Flow | 120.08 | 22.04 | 135.69 | 88.29 | 12.88 | 37.13 | Upgrade
|
| Unlevered Free Cash Flow | 120.7 | 22.32 | 136.43 | 88.8 | 13.41 | 38.14 | Upgrade
|
| Change in Working Capital | 44.05 | 44.05 | 114.62 | -5.04 | 44.54 | 40.92 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.